Life Sciences M&A | McDermott Life Sciences Lawyers

Life Sciences
Mergers & Acquisitions


IAM Patent 1000

The strategy behind your business growth

Pushing boundaries and moving forward, you’re always looking for what’s next. Be ready to take advantage of merger and acquisition opportunities with a hand-selected team of legal advisors by your side. We’ll navigate the complex and highly regulated life sciences landscape and help prevent challenges from holding you back. So you can keep moving at the pace of innovation.

It’s what we do: we fuel missions and knock down barriers to successfully negotiate and close deals on behalf of life sciences businesses large and small, worldwide.

Show More


  • Siegfried Group on multiple transactions including the acquisition of significant parts of BASF’s pharmaceutical supply business and connected chemical-pharmaceutical production units and the acquisition of Hameln Pharmaceuticals and Hameln RDS, developers of sterile pharmaceutical products
  • Alliant Pharmaceuticals, Inc., with an approximately $100 million sale to Sciele Pharma, Inc.
  • Baird Capital Partners Asia and Frontage Laboratories in the acquisition of Advanced Biomedical Research, Inc., a clinical research company

Show More


Our integrated, global team of life sciences transaction leaders bring highly focused skills and broad industry experience to bear on all elements of a transaction.